| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.19B | 25.33B | 22.68B | 23.23B | 21.07B | 17.87B |
| Gross Profit | 9.72B | 9.79B | 8.74B | 8.77B | 7.92B | 7.04B |
| EBITDA | 5.45B | 5.54B | 4.43B | 5.40B | 4.54B | 3.67B |
| Net Income | 3.17B | 3.11B | 2.15B | 3.16B | 2.70B | 1.93B |
Balance Sheet | ||||||
| Total Assets | 30.55B | 31.20B | 28.25B | 25.99B | 23.72B | 19.88B |
| Cash, Cash Equivalents and Short-Term Investments | 11.13B | 12.14B | 10.56B | 8.70B | 5.57B | 5.26B |
| Total Debt | 2.65B | 2.79B | 3.05B | 3.13B | 3.80B | 4.05B |
| Total Liabilities | 7.95B | 7.97B | 6.86B | 7.05B | 8.13B | 8.13B |
| Stockholders Equity | 22.60B | 23.22B | 21.40B | 18.94B | 15.59B | 11.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | 2.97B | 3.82B | 624.11M | 1.27B |
| Operating Cash Flow | 0.00 | 5.19B | 3.73B | 4.80B | 2.11B | 2.67B |
| Investing Cash Flow | 0.00 | -1.51B | -626.15M | -740.66M | -1.45B | -1.73B |
| Financing Cash Flow | 0.00 | -1.82B | -1.67B | -1.03B | -706.72M | -671.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥153.25B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
74 Outperform | ¥5.27T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥26.67B | 7.34 | ― | 1.78% | 2.37% | 10.77% | |
73 Outperform | ¥9.48T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
73 Outperform | ¥18.91B | 13.39 | ― | 2.93% | 6.01% | 0.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥1.10T | 36.79 | 2.99% | 2.62% | 5.80% | 215.16% |